TY - JOUR
T1 - Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
AU - International ICI-Myocarditis Registry
AU - Power, John R.
AU - Alexandre, Joachim
AU - Choudhary, Arrush
AU - Ozbay, Benay
AU - Hayek, Salim S.
AU - Asnani, Aarti
AU - Tamura, Yuichi
AU - Aras, Mandar
AU - Cautela, Jennifer
AU - Thuny, Franck
AU - Gilstrap, Lauren
AU - Arangalage, Dimitri
AU - Ewer, Steven
AU - Huang, Shi
AU - Deswal, Anita
AU - Palaskas, Nicolas L.
AU - Finke, Daniel
AU - Lehmann, Lorenz H.
AU - Ederhy, Stephane
AU - Moslehi, Javid
AU - Salem, Joe Elie
N1 - Publisher Copyright:
© 2022 Elsevier Masson SAS
PY - 2022/5
Y1 - 2022/5
N2 - Background: Immune-checkpoint inhibitor-associated myocarditis (ICI-myocarditis) often presents with arrhythmias, but the prognostic value of early electrocardiogram findings is unclear. Although ICI-myocarditis and acute cellular rejection (ACR) following cardiac transplantation use similar treatment strategies, differences in arrhythmia burden are unknown. Objective: To evaluate the association of electrocardiogram findings in ICI-myocarditis with myocarditis-related mortality and life-threatening arrhythmia. Methods: A total of 125 cases of ICI-myocarditis were identified retrospectively across 49 hospitals worldwide; 50 cases of grade 2R or 3R ACR were included as comparators. Two cardiologists blinded to clinical data interpreted electrocardiograms. Associations between electrocardiogram features, myocarditis-related mortality and the composite of myocarditis-related mortality and life-threatening arrhythmias were examined. Adjusted hazard ratios (aHRs) were calculated. Results: The cohort had 78 (62.4%) men; median (interquartile range) age was 67 (58–76) years. At 30 days, myocarditis-related mortality was 20/124 (16.1%), and 28/124 (22.6%) met the composite endpoint. Patients who developed complete heart block (aHR by subdistribution hazards model [aHR(sh)] 3.29, 95% confidence interval [CI] 1.24–8.68; P = 0.02) or life-threatening cardiac arrhythmias (aHR(sh) 6.82, 95% CI: 2.87–16.21; P < 0.001) had a higher risk of myocarditis-related mortality. Pathological Q waves (aHR(sh) 3.40, 95% CI: 1.38–8.33; P = 0.008), low QRS voltage (aHR(sh) 6.05, 95% CI: 2.10–17.39; P < 0.001) and Sokolow-Lyon index (aHR(sh)/mV 0.54, 95% CI: 0.30–0.97; P = 0.04) on admission electrocardiogram were also associated with increased risk of myocarditis-related mortality. These associations were mirrored in the composite outcome analysis. Compared with ACR, ICI-myocarditis had a higher incidence of life-threatening cardiac arrhythmias (15/125 [12.0%] vs 1/50 [2%]; P = 0.04) and third-degree heart block (19/125 [15.2%] vs 0/50 [0%]; P = 0.004). Conclusions: Electrocardiograms in ICI-myocarditis with ventricular tachycardias, heart block, low-voltage and pathological Q waves were associated with myocarditis-related mortality and life-threating arrhythmia. Arrhythmia burden in ICI-myocarditis exceeds that of ACR after heart transplant.
AB - Background: Immune-checkpoint inhibitor-associated myocarditis (ICI-myocarditis) often presents with arrhythmias, but the prognostic value of early electrocardiogram findings is unclear. Although ICI-myocarditis and acute cellular rejection (ACR) following cardiac transplantation use similar treatment strategies, differences in arrhythmia burden are unknown. Objective: To evaluate the association of electrocardiogram findings in ICI-myocarditis with myocarditis-related mortality and life-threatening arrhythmia. Methods: A total of 125 cases of ICI-myocarditis were identified retrospectively across 49 hospitals worldwide; 50 cases of grade 2R or 3R ACR were included as comparators. Two cardiologists blinded to clinical data interpreted electrocardiograms. Associations between electrocardiogram features, myocarditis-related mortality and the composite of myocarditis-related mortality and life-threatening arrhythmias were examined. Adjusted hazard ratios (aHRs) were calculated. Results: The cohort had 78 (62.4%) men; median (interquartile range) age was 67 (58–76) years. At 30 days, myocarditis-related mortality was 20/124 (16.1%), and 28/124 (22.6%) met the composite endpoint. Patients who developed complete heart block (aHR by subdistribution hazards model [aHR(sh)] 3.29, 95% confidence interval [CI] 1.24–8.68; P = 0.02) or life-threatening cardiac arrhythmias (aHR(sh) 6.82, 95% CI: 2.87–16.21; P < 0.001) had a higher risk of myocarditis-related mortality. Pathological Q waves (aHR(sh) 3.40, 95% CI: 1.38–8.33; P = 0.008), low QRS voltage (aHR(sh) 6.05, 95% CI: 2.10–17.39; P < 0.001) and Sokolow-Lyon index (aHR(sh)/mV 0.54, 95% CI: 0.30–0.97; P = 0.04) on admission electrocardiogram were also associated with increased risk of myocarditis-related mortality. These associations were mirrored in the composite outcome analysis. Compared with ACR, ICI-myocarditis had a higher incidence of life-threatening cardiac arrhythmias (15/125 [12.0%] vs 1/50 [2%]; P = 0.04) and third-degree heart block (19/125 [15.2%] vs 0/50 [0%]; P = 0.004). Conclusions: Electrocardiograms in ICI-myocarditis with ventricular tachycardias, heart block, low-voltage and pathological Q waves were associated with myocarditis-related mortality and life-threating arrhythmia. Arrhythmia burden in ICI-myocarditis exceeds that of ACR after heart transplant.
KW - Cardio-oncology
KW - Electrophysiology
KW - Immunotherapy
KW - Myocarditis
UR - http://www.scopus.com/inward/record.url?scp=85130347584&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130347584&partnerID=8YFLogxK
U2 - 10.1016/j.acvd.2022.03.003
DO - 10.1016/j.acvd.2022.03.003
M3 - Article
C2 - 35595646
AN - SCOPUS:85130347584
SN - 1875-2136
VL - 115
SP - 315
EP - 330
JO - Archives of Cardiovascular Diseases
JF - Archives of Cardiovascular Diseases
IS - 5
ER -